BQ123: Clinical Trials

3 trials of BQ123, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 11Withdrawn 1

Follow BQ123: new trials by email Literature Review of BQ123 trials Research Report on BQ123

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes
Insulin clamp, BQ123, BQ123 + BQ788 - Type2 Diabetes
Not applicableUnknownUniversity of Southern Denmark222018-05-012021-06-01
Endothelin Antagonism in ANCA Vasculitis
BQ123, BQ123/788, Placebo - Vasculitis
Not applicableCompletedUniversity of Edinburgh642016-08-012023-11-29
The Role of Endothelin in the Supine Hypertension of Autonomic Failure
BQ123, Bq123, Saline - Hypertension, Pure Autonomic Failure
Phase 1WithdrawnVanderbilt University2010-05-012021-10-05

Conditions studied

Hypertension (1)  ·  Multiple System Atrophy (1)  ·  Pure Autonomic Failure (1)  ·  Vasculitis (1)

Sponsors

University of Edinburgh (1)  ·  University of Southern Denmark (1)  ·  Vanderbilt University (1)

Countries

Denmark (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Italo Biaggioni, M.D. (1)  ·  Neeraj Dhaun (1)  ·  Stefan Mortensen, DMSc (1)

Results publications

PMID 35084435, PMID 35998848